The results were filtered under de novo dominance and recessive hypotheses. 1,2 and covered by at least 10 reads were prioritized for validation (it should be noted that those who carried out the original DECIPHER analysis and collection of the data bear no responsibility for the further analysis or interpretation of it). In parallel, variant effects were classified as high, moderate or low according to SnpEff 3 and mutations with a high putative effect and at least 10 reads were also prioritized for validation by Sanger sequencing.
Whole Genome Sequencing
Reads were aligned to the human genome (hg19) using BWA mem (v.0.7.10) 4 . considering different inheritance models in the family trio. The software also evaluates the effects of a given variation on the coding protein using a number of predictive tools (SIFT, Polyphen2, Condel, and other).
In the result, EDiVa identified two compound and two de novo mutations affecting three genes, among which was the de novo nonsense mutation affecting the MAGEL2 gene. PhenoDB detected 93 de novo autosomal dominant SNVs, applying a cut off on the CCDS intolerance percentile of 10%
and retaining public SNPs with frequency smaller than 0.005. OMIM data were available for four genes in which de novo SNVs were identified. The nonsense mutation in MAGEL2 was detected and classified as "pathogenic", while the other three mutations were classified as "likely pathogenic" and of "uncertain significance".
Phasing the de novo Mutation in MAGEL2
One hundred ng of the patient and parent's gDNA was digested with the methylation-sensitive enzyme SmaI (Fermentas, Thermo Fischer Scientific, Waltham, MA, EUA). The PCR products were purified with the MultiScreenTM Vacuum Manifold 96-well plate (Merck Millipore, Bellerica, MA, USA) following the manufacturer's instructions and quantified using a NanoDrop ND-1000
Spectrophotometer (Nanodrop Technologies Inc., Wilmington, DE, USA). A 2.28 kb region including the mutation and methylation sites was amplified using primers MAGEL2-LR-F and MAGEL2-LR-R (Table S1) 
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